Melrose, MA, United States of America

Magnus Rönn


 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Magnus Rönn: Advancements in Tetracycline Compounds

Introduction

Magnus Rönn, an esteemed inventor based in Melrose, MA, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of four patents, Rönn focuses primarily on the development of polycyclic tetracycline compounds, which have substantial therapeutic implications.

Latest Patents

Rönn's latest innovations include groundbreaking patents for polycyclic tetracycline compounds. These inventions involve a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are meticulously defined in his patents. Additionally, these patents describe pharmaceutical compositions comprising the compound and its therapeutic uses, emphasizing their potential in treating various medical conditions. Another notable patent is directed towards tetracycline compounds, which similarly follows the Structural Formula (I) framework and outlines its implications in pharmaceutical compositions.

Career Highlights

Currently, Magnus Rönn is associated with Tetraphase Pharmaceuticals, Inc., where his research and developments pave the way for novel therapeutic solutions. His expertise and innovative approach have established him as a prominent figure in his field, contributing to advancements in antibiotic therapies.

Collaborations

Throughout his career, Rönn has collaborated with talented professionals including Roger B Clark and Minsheng He. These collaborations have fostered a creative environment, allowing for the exchange of ideas and focusing on achieving breakthrough innovations in pharmaceutical development.

Conclusion

In summary, Magnus Rönn stands out as a notable inventor who has made significant strides in the world of tetracycline compounds. His patents not only reflect his dedication to pharmaceutical innovation but also the potential they hold in enhancing medical treatments. As he continues to develop and refine his inventions, the impact of his work is sure to resonate throughout the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…